ATYR vs GSK · rev $190.0K vs P/E 13, $103.31B cap
aTyr Pharma, Inc. (ATYR) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported ATYR revenue for 2025-09-30 was $190.0K. Net income was -$25.7M. ATYR currently screens at market cap $471.7M.
GSK does not have a complete income-statement cache yet.
ATYR currently screens at market cap $471.7M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the ATYR and GSK stock pages for the full models.
Not investment advice.